<SEC-DOCUMENT>0001213900-24-037854.txt : 20240430
<SEC-HEADER>0001213900-24-037854.hdr.sgml : 20240430
<ACCEPTANCE-DATETIME>20240430161853
ACCESSION NUMBER:		0001213900-24-037854
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20240430
FILED AS OF DATE:		20240430
DATE AS OF CHANGE:		20240430

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Moolec Science SA
		CENTRAL INDEX KEY:			0001937737
		STANDARD INDUSTRIAL CLASSIFICATION:	BLANK CHECKS [6770]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			N4
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41586
		FILM NUMBER:		24897548

	BUSINESS ADDRESS:	
		STREET 1:		17, BOULEVARD F.W. RAIFFEISAN
		CITY:			LUXEMBOURG
		STATE:			N4
		ZIP:			L-2411
		BUSINESS PHONE:		352 26 49 65 65

	MAIL ADDRESS:	
		STREET 1:		17, BOULEVARD F.W. RAIFFEISAN
		CITY:			LUXEMBOURG
		STATE:			N4
		ZIP:			L-2411
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>ea0205017-6k_moolec.htm
<DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form&nbsp;6-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Report
of Foreign Private Issuer</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pursuant
to Rules&nbsp;13a-16 or 15d-16 under</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>the
Securities Exchange Act of 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the month of April 2024</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Commission
File Number: 001-41586</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MOOLEC
SCIENCE SA </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of Registrant as Specified in Its Charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>17,
Boulevard F. W. Raiffeisen</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>L-2411
Luxembourg,</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Grand
Duchy of Luxembourg</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
of principal executive offices)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant files or will file annual reports under cover Form&nbsp;20-F or Form&nbsp;40-F.</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&nbsp;20-F&nbsp;&#9746;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Form&nbsp;40-F&nbsp;&nbsp;&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
List</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
    No.&nbsp;</B></FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 89%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description&nbsp;</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><A HREF="ea020501701ex99-1_moolec.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release of Moolec Science SA dated April 30, 2024.</FONT></A></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MOOLEC SCIENCE SA</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 61%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 34%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: April 30,
    2024</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid">/s/ <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gast&oacute;n Paladini</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp; </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gast&oacute;n Paladini</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ea020501701ex99-1_moolec.htm
<DESCRIPTION>PRESS RELEASE OF MOOLEC SCIENCE SA DATED APRIL 30, 2024
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 10pt"><B>Exhibit 99.1</B>&nbsp;</FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-size: 10pt"><IMG SRC="ex99-1_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Moolec
Announces New Patent Granting in the United States For Molecular Farming Platform</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">Luxembour<FONT STYLE="background-color: white">g.
April 30, 2024</FONT> -&nbsp;Moolec Science SA&nbsp;(NASDAQ: MLEC; &ldquo;Company&rdquo;; &ldquo;Moolec&rdquo;), a Molecular Farming
food-ingredient company<FONT STYLE="background-color: white">, announced today the granting of a patent family in the United States for
its SPC2 product produced in safflower with Molecular Farming technology. This new patent adjudication will give the company, through
its US sole owned subsidiary AG Biomolecules LLC, exclusivity for the </FONT>use of the technology until 2041. <FONT STYLE="background-color: white">Find
the link to the patent here: <U STYLE="text-decoration: none">https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/11965169</U></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">Moolec, whose technological
platform has been under development for more than a decade, is known for pioneering the production of a bovine protein in a crop for
the food industry. With the development and commercialization of the world&rsquo;s first product for the food industry using Molecular Farming,
Moolec shattered barriers and revealed the potential of this groundbreaking technology in the industrial biotech sector. This milestone
transcended the limitations of traditional biotech practices, opening doors to innovation previously confined to pharmaceuticals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">The recently patented
technology encompasses safflower plants, inclusive of their seeds, engineered with specific DNA sequences (transgenic event) aimed at
improving the expression of bovine chymosin in safflower seeds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">Amit Dhingra, Moolec
Science&rsquo;s Chief Science Officer, emphasized: <I>&ldquo;This new family of patents not only ensures intellectual property protection for
our product but also represents a platform for additional opportunities for Moolec&rsquo;s safflower platform&rdquo;. He then finished
by saying: &ldquo;It positions us to produce new proteins and products, leveraging the unique attributes of this crop. Moolec remains
committed to innovative advancements in sustainable biotechnology, driving impactful change across food industries.&rdquo;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">Additionally, the
patent extends to cover the DNA vectors utilized for transforming the safflower plant and the DNA sequences required for detecting the
transgenic event.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">While the patent
has been successfully secured in the United States, a parallel application has been submitted in Argentina, a crucial strategic territory
for Moolec&rsquo;s safflower technology initiatives. Although the Argentinian patent application is currently pending, the patent family boasts
a lifespan extending until 2041.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 10pt"><IMG SRC="ex99-1_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">About Moolec Science
SA</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">Moolec is a science-based
ingredient company leader in the use of Molecular Farming technology for food and dietary supplementation markets. The Company&rsquo;s
mission is to create unique food ingredients by engineering plants with animal protein genes. Its purpose is to redefine the way the
world produces animal proteins, for good and for all. Moolec&rsquo;s technological approach aims to have the cost structure of plant-based
solutions with the nutrition and functionality of animal-based ones. Moolec&rsquo;s technology has been under development for more than
a decade and is known for pioneering the production of a bovine protein in a crop for the food industry. The Company&rsquo;s product
portfolio and pipeline leverage the agronomic efficiency of broadly used target crops, like soybean, pea, and safflower to produce oils
and proteins. Moolec also has an industrial and commercial R&amp;D capability to complement the company&rsquo;s Molecular Farming technology.
Moolec secures a growing international patent portfolio (25+, both granted and pending) for its Molecular Farming technology. The Company
is run by a diverse team of Ph.Ds and Food Insiders, and operates in the United States, Europe, and South America. For more information,
visit <U STYLE="text-decoration: none">moolecscience.com</U> and <U STYLE="text-decoration: none">ir.moolecscience.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">Forward-Looking
Statements</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">This press release
contains &ldquo;forward-looking statements.&rdquo; Forward-looking statements may be identified by the use of words such as &ldquo;forecast,&rdquo;
&ldquo;intend,&rdquo; &ldquo;seek,&rdquo; &ldquo;target,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo; &ldquo;expect,&rdquo;
&ldquo;estimate,&rdquo; &ldquo;plan,&rdquo; &ldquo;outlook,&rdquo; and &ldquo;project&rdquo; and other similar expressions that predict
or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements with respect to
performance, prospects, revenues, and other aspects of the business of Moolec are predictions, projections and other statements about
future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Although
we believe that we have a reasonable basis for each forward-looking statement contained in this press release, we caution you that these
statements are based on a combination of facts and factors, about which we cannot be certain. We cannot assure you that the forward-looking
statements in this press release will prove accurate. These forward-looking statements are subject to a number of significant risks and
uncertainties that could cause actual results to differ materially from expected results, including, among others, changes in applicable
laws or regulations, the possibility that Moolec may be adversely affected by economic, business and/or other competitive factors, costs
related to the scaling up of Moolec&rsquo;s business and other risks and uncertainties, including those included under the header &ldquo;Risk
Factors&rdquo; in Moolec&rsquo;s Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission (&ldquo;SEC&rdquo;),
as well as Moolec&rsquo;s other filings with the SEC. Should one or more of these risks or uncertainties materialize, or should any of
our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements.
We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events
or otherwise, except as may be required under applicable securities laws. Accordingly, you should not put undue reliance on these statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">Contacts:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Press
                                            &amp; Media inquiries | <U STYLE="text-decoration: none">comms@moolecscience.com</U></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Investor
                                            Relations inquiries: <U STYLE="font-family: Times New Roman, Times, Serif; text-decoration: none">ir@moolecscience.com</U> | <U STYLE="text-decoration: none">MoolecIR@icrinc.com</U></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !I )X# 2(  A$! Q$!_\0
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M\"&X!B<GT&[ )^E '84444 %%%% !0> 317G/QJ\52>&? <R6LA2\U%_LL3
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MTR"+[&L)&': YRW^]D[L>P%;]YH_PEU7Q&?%K^+%BADE%U+IY&"TF=Q&W&X
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M/PA8+:Z/8I#_ 'YF&Z60^K-U/\JF\1>%M&\5:>]GK%C'<QD?*Q&'0^JL.0:
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M** $VCTHP/2EHH 3 ]*-H'0"EHH 3:/04;1Z"EHH 3:/2C SG'-+10 4444
+%%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
